Why is Saroja Pharma In falling/rising?

As of 11-Nov, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.9 or 4.4%. The stock has underperformed its sector by 4.27% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 66.67% compared to the 5-day average. Over the past week, the stock has decreased by 4.40%, and it has also shown a substantial decline of 31.25% year-to-date, indicating ongoing challenges for the company.
In the broader market context, while Saroja Pharma's stock has fallen significantly, the benchmark Sensex has shown a slight increase of 0.38% over the past week and a gain of 8.67% year-to-date. This stark contrast highlights the stock's underperformance relative to the market. The overall negative sentiment surrounding Saroja Pharma, as evidenced by its declining price and reduced trading activity, suggests that investors may be losing confidence in the company's prospects, further contributing to its downward trajectory.